Clinical trial
Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®
NCT00274261 · Premier Research, Other · Completed
Key facts
| NCT number | NCT00274261 |
|---|---|
| Title | Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol® |
| Official title | A Phase II/III Multicenter, Randomized, Double-masked, Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol® |
| Lead sponsor | Premier Research, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pregnancy |
| Intervention type | Drug |
| Interventions | C31G, nonoxynol-9 (N-9) |
| Enrollment | 1,565 |
| Start date | Jun 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jan 10, 2006 |
| Last update posted | May 1, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: